Another major title in the works is good news for Axion Ventures (Axion Ventures News, Stock Quote, Chart TSXV:AXV), according to PI Financial analyst David Kwan, who on Tuesday maintained his “Buy” rating and $1.75 target on the stock.
Video game company Axion on Monday announced the signing of an MOU with a leading game developer to begin joint development of a new video game to be released on multiple platforms. A prototype is expected to be completed in Q4 of this year with a commercial launch expected in late 2020 worldwide.
Axion management said that due to the “highly sensitive nature” of the game, further details won’t be available until a later date.
Kwan says AXV will likely be hiring more developers, artists and personnel, as the company has limited resources given its ongoing work with Rising Fire as well as other games in its pipeline. The analyst says that a key Rising Fire update will be coming by mid-September.
On the new joint venture, Kwan says in a client update, “We are lacking details on such things as the economics (e.g., JV structure/ownership, revenue share, development costs, etc.), game genre, etc. That said, we assume AXV’s partner will take a majority stake in the JV and will be responsible for marketing the game when commercialized.”
The analyst is taking the new JV announcement as a positive for the stock while leaving his estimates unchanged until further details emerge.
Kwan says, “We believe the recent share price weakness has created an excellent buying opportunity ahead of a key (and highly anticipated) update on RF and the announcement of licensing deals for RF (and possibly Invictus).”
Kwan’s $1.75 target represented a projected return of 150 per cent at the time of publication.
Research Capital analyst Greg McLeish said in a July 29 update that Cannara Biotech (Cannara Biotech Stock Quote, Chart, News,… [Read More]
Beacon Securities analyst Gabriel Leung noted in a July 30 report that Tantalus Systems (Tantalus Systems Holding Stock Quote, Chart,… [Read More]
Roth Capital Markets is initiating coverage of Sanuwave Health (Sanuwave Health Stock Quote, Chart, News, Analysts, Financials NASDAQ:SNWV) with a… [Read More]
Roth Capital Markets analyst Jason Wittes noted in a July 28 pre-IPO report that Shoulder Innovations, a new entrant in… [Read More]
Roth Capital Markets analyst Philip Shen said in a July 28 earnings preview that Nextracker (Nextracker Stock Quote, Chart, News,… [Read More]
Brian Madden, Chief Investment Officer at First Avenue Investment Counsel, said on BNN Bloomberg’s Market Call on July 25 that… [Read More]